Drugs / BCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02389322 Background | Mar → Jul 2015 | tuberculosis | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02389322 ↗ |
| Modality | Vaccine | “BCG vaccine” NCT02389322 ↗ |
| Route | Other | “The participants are injected intradermally with 0.1 ml BCG.” NCT02389322 ↗ |